Patents by Inventor Daniel Zickler

Daniel Zickler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Permselective membrane for treating vascular calcifications in chronic hemodialysis patients
    Patent number: 11103624
    Abstract: The present disclosure relates to a hemodialysis membrane for the treatment of vascular calcification in hemodialysis patients, especially in chronic hemodialysis patients. The present disclosure further relates to methods of treating vascular calcification in hemodialysis patients, wherein the hemodialysis membrane is characterized in that it comprises at least one hydrophobic polymer and at least one hydrophilic polymer and in that it has a MWRO of between 15 and 20 kD and a MWCO of between 170-320 kD or that the hemodialysis membrane comprises at least one hydrophobic polymer and at least one hydrophilic polymer and has a MWRO of between 8.5 kD and 14.0 kD and a MWCO of between 55 kD and 130 kD.
    Type: Grant
    Filed: April 18, 2018
    Date of Patent: August 31, 2021
    Assignees: GAMBRO LUNDIA AB, CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN
    Inventors: Markus Storr, Bernd Krause, Ralf Schindler, Daniel Zickler, Bjoern Hegner
  • PERMSELECTIVE MEMBRANE FOR TREATING VASCULAR CALCIFICATIONS IN CHRONIC HEMODIALYSIS PATIENTS
    Publication number: 20180228958
    Abstract: The present disclosure relates to a hemodialysis membrane for the treatment of vascular calcification in hemodialysis patients, especially in chronic hemodialysis patients. The present disclosure further relates to methods of treating vascular calcification in hemodialysis patients, wherein the hemodialysis membrane is characterized in that it comprises at least one hydrophobic polymer and at least one hydrophilic polymer and in that it has a MWRO of between 15 and 20 kD and a MWCO of between 170-320 kD or that the hemodialysis membrane comprises at least one hydrophobic polymer and at least one hydrophilic polymer and has a MWRO of between 8.5 kD and 14.0 kD and a MWCO of between 55 kD and 130 kD.
    Type: Application
    Filed: April 18, 2018
    Publication date: August 16, 2018
    Inventors: Markus STORR, Bernd KRAUSE, Ralf SCHINDLER, Daniel ZICKLER, Bjoern HEGNER
  • Permselective membrane for treating vascular calcifications in chronic hemodialysis patients
    Patent number: 9974895
    Abstract: The present disclosure relates to a hemodialysis membrane for the treatment of vascular calcification in hemodialysis patients, especially in chronic hemodialysis patients. The present disclosure further relates to methods of treating vascular calcification in hemodialysis patients, wherein the hemodialysis membrane is characterized in that it comprises at least one hydrophobic polymer and at least one hydrophilic polymer and in that it has a MWRO of between 15 and 20 kD and a MWCO of between 170-320 kD or that the hemodialysis membrane comprises at least one hydrophobic polymer and at least one hydrophilic polymer and has a MWRO of between 8.5 kD and 14.0 kD and a MWCO of between 55 kD and 130 kD.
    Type: Grant
    Filed: October 10, 2014
    Date of Patent: May 22, 2018
    Assignees: GAMBRO LUNDIA AB, CHARITE UNIVERSITATSMEDIZIN BERLIN
    Inventors: Markus Storr, Bernd Krause, Ralf Schindler, Daniel Zickler, Bjoern Hegner
  • Permselective Membrane for Treating Vascular Calcifications in Chronic Hemodialysis Patients
    Publication number: 20150110887
    Abstract: The present disclosure relates to a hemodialysis membrane for the treatment of vascular calcification in hemodialysis patients, especially in chronic hemodialysis patients. The present disclosure further relates to methods of treating vascular calcification in hemodialysis patients, wherein the hemodialysis membrane is characterized in that it comprises at least one hydrophobic polymer and at least one hydrophilic polymer and in that it has a MWRO of between 15 and 20 kD and a MWCO of between 170-320 kD or that the hemodialysis membrane comprises at least one hydrophobic polymer and at least one hydrophilic polymer and has a MWRO of between 8.5 kD and 14.0 kD and a MWCO of between 55 kD and 130 kD.
    Type: Application
    Filed: October 10, 2014
    Publication date: April 23, 2015
    Inventors: Markus Storr, Bernd Krause, Ralf Schindler, Daniel Zickler, Bjoern Hegner